The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Modeling COVID-19 scenarios for the United States
Open accessPublished version of a preprint
Abstract
We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministic SEIR (susceptible, exposed, infectious and recovered) compartmental framework to model possible trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the effects of non-pharmaceutical interventions in the United States at the state level from 22 September 2020 through 28 February 2021. Using this SEIR model, and projections of critical driving covariates (pneumonia seasonality, mobility, testing rates and mask use per capita), we assessed scenarios of social distancing mandates and levels of mask use. Projections of current non-pharmaceutical intervention strategies by state—with social distancing mandates reinstated when a threshold of 8 deaths per million population is exceeded (reference scenario)—suggest that, cumulatively, 511,373 (469,578–578,347) lives could be lost to COVID-19 across the United States by 28 February 2021. We find that achieving universal mask use (95% mask use in public) could be sufficient to ameliorate the worst effects of epidemic resurgences in many states. Universal mask use could save an additional 129,574 (85,284–170,867) lives from September 22, 2020 through the end of February 2021, or an additional 95,814 (60,731–133,077) lives assuming a lesser adoption of mask wearing (85%), when compared to the reference scenario.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ultimately, we considered three novel indicators of the COVID-19 pandemic: decreasing human mobility,13 estimated total (as opposed to reported) daily SARS-CoV-2 infection rate, and estimated daily excess mortality rate during the pandemic (including excess deaths occurring during the pandemic where COVID-19 was not reported as the underlying cause of death).5, 13”
From Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The estimation of human mobility, daily SARS-CoV-2 infection rate, and daily excess mortality rate was done by the Institute for Health Metrics and Evaluation (IHME) COVID-19 Forecasting Team and is described in detail elsewhere.13”
From Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This variation can be explained by a combination of factors including policies enacted by governments to encourage mask use and reduce social interaction,48, 49, 50 presence of escape variants, testing and contact tracing capacity,51, 52 previous exposure to other coronaviruses,53 baseline patterns of social interaction, and more.”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationMurray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationRemdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., Chu, D. K., Akl, E. A., El-harakeh, A., Bognanni, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31142-9 · Cited by 3,843
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,350
Research works printed but not linked: 3
- Horton, R. The COVID-19 Catastrophe: What’s Gone Wrong and How to Stop it Happening Again. (John Wiley & Sons, 2020).
- GBD 2019 Population and Fertility Collaborators. Global, regional and national age-sex-specific fertility, mortality and population estimates, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019. The Lancet (in press).
- GBD 2019 Diseases and injuries Collaborators. Global burden of 369 diseases and injuries, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet (in press).
Cited by
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
Self-citationThe Global Burden of Disease Study at 30 years
Murray, C. J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01990-1 · Cited by 856
Self-citationCovasim: An agent-based model of COVID-19 dynamics and interventions
Kerr, C. C., Stuart, R. M., Mistry, D., Abeysuriya, R. G., Rosenfeld, K., Hart, G. R., Núñez, R. C., Cohen, J. A., Selvaraj, P., Hagedorn, B., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009149 · Cited by 685
Non-pharmaceutical interventions during the COVID-19 pandemic: A review
Perra, N. (2021) · Physics Reports · doi:10.1016/j.physrep.2021.02.001 · Cited by 531
Naghavi, M., Kyu, H. H., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abafita, B. J., Abaraogu, U. O., Abbafati, C., Abbasi, M., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01917-8 · Cited by 595
Metadata
- Authors
- IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., Bang-Jensen, B., Bannick, M. S., Bloom, S., Carter, A., Castro, E., Causey, K., Chakrabarti, S., Charlson, F. J., Cogen, R. M., Combs, E., Dai, X., Dangel, W. J., Earl, L., Ewald, S. B., Ezalarab, M., Ferrari, A. J., Flaxman, A., Frostad, J. J., Fullman, N., Gakidou, E., Gallagher, J., Glenn, S. D., Goosmann, E. A., He, J., Henry, N. J., Hulland, E. N., Hurst, B., Johanns, C., Kendrick, P. J., Khemani, A., Larson, S. L., Lazzar-Atwood, A., LeGrand, K. E., Lescinsky, H., Lindstrom, A., Linebarger, E., Lozano, R., Ma, R., Månsson, J., Magistro, B., Herrera, A. M. M., Marczak, L. B., Miller-Petrie, M. K., Mokdad, A. H., Morgan, J. D., Naik, P., Odell, C. M., O’Halloran, J. K., Osgood-Zimmerman, A. E., Ostroff, S. M., Pasovic, M., Penberthy, L., Phipps, G., Pigott, D. M., Pollock, I., Ramshaw, R. E., Redford, S. B., Reinke, G., Rolfe, S., Santomauro, D. F., Shackleton, J. R., Shaw, D. H., Sheena, B. S., Sholokhov, A., Sorensen, R. J. D., Sparks, G., Spurlock, E. E., Subart, M. L., Syailendrawati, R., Torre, A. E., Troeger, C. E., Vos, T., Watson, A., Watson, S., Wiens, K. E., Woyczynski, L., Xu, L., Zhang, J., Hay, S. I., Lim, S. S., & Murray, C. J. L.
- Affiliations
- University of Washington (US)
- The University of Queensland (AU)
- ORCID
- Reiner, Robert C.
- Barber, Ryan M.
- Collins, James K.
- Adolph, Christopher
- Albright, James
- Aravkin, Aleksandr Y.
- Bang-Jensen, Bree
- Bannick, Marlena S.
- Carter, Austin
- Causey, Kate
- Chakrabarti, Suman
- Charlson, Fiona J.
- Dai, Xiaochen
- Ewald, Samuel B.
- Ferrari, Alize J.
- Flaxman, Abraham
- Fullman, Nancy
- Gakidou, Emmanuela
- Glenn, Scott D.
- Goosmann, Erik A.
- He, Jiawei
- Henry, Nathaniel J.
- Hulland, Erin N.
- Kendrick, Parkes J.
- LeGrand, Kate E.
- Lindstrom, Akiaja
- Lozano, Rafael
- Ma, Rui
- Magistro, Beatrice
- Herrera, Ana M. Mantilla
- Marczak, Laurie B.
- Miller-Petrie, Molly K.
- Mokdad, Ali H.
- Naik, Paulami
- Osgood-Zimmerman, Aaron E.
- Pasovic, Maja
- Pigott, David M.
- Ramshaw, Rebecca E.
- Reinke, Grace
- Santomauro, Damian Francesco
- Sheena, Brittney S.
- Sholokhov, Aleksei
- Sorensen, Reed J. D.
- Spurlock, Emma Elizabeth
- Vos, Theo
- Wiens, Kirsten E.
- Hay, Simon I.
- Lim, Stephen S.
- Murray, Christopher J. L.
- Venue
- Nature Medicine
- Published
- 2020-10-23
- Volume
- 27
- Issue
- 1
- Pages
- 94-105
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC7806509
- OpenAlex
- W3093610264
- Cited by
- 556
- References
- 56
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 61 · 2023: 84 · 2022: 134 · 2021: 210 · 2020: 25
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-11-27)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- National Science Foundation (2031096)
- Bill and Melinda Gates Foundation
- Institute for Health Metrics and Evaluation
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Keywords
- COVID-19 pandemic, SARS-CoV-2, SEIR model, epidemic projection, non-pharmaceutical interventions, masking, mortality, mobility, testing rates, epidemic resurgence, United States
- MeSH terms
- Physical Distancing, COVID-19, SARS-CoV-2, Health Policy, Humans, Models, Biological, Travel, United States, Epidemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modeling COVID-19 scenarios for the United States. https://app.cochat.ai/papers/10.1038/s41591-020-1132-9
- The paper
- IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., Bang-Jensen, B., Bannick, M. S., Bloom, S., Carter, A., Castro, E., Causey, K., Chakrabarti, S., Charlson, F. J., Cogen, R. M., . . . Murray, C. J. L. (2021). Modeling COVID-19 scenarios for the United States. Nature Medicine. https://doi.org/10.1038/s41591-020-1132-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.